American Oriental Bioengineering has struck a deal with Palm Beach Clinical Research Organization (PBCRO) of the US to use PBCRO to oversee American clinical trials of AOBO-developed pharmaceuticals. American Oriental did not disclose which of its products it plans to enter into the process of FDA registration. AOBO, which is headquartered in the Beijing E-Town Economic and Technology Development Area, makes both prescription and OTC products. More details....

Stock Symbol: (NYSE: AOB)